One of the most attractive business sector is pharmacy. The market for pharmaceuticals is characterized by huge investments as well as big profits. In the Czech Republic, the turnover of the pharmaceutical market for more than 50 billion a year. The pharmaceutical industry contributes significantly to the quality of life. It is a strategic sector, which relates to public health and has a significant economic dimension.
Thriving pharmaceutical industry is essential to ensure a high level of protection of public health. Oversees compliance with EU principles of free movement of pharmaceuticals and medical devices, as well as to ensure high standards of quality and safety. EU seeks from its inception to create a single European market in pharmaceuticals, strives for fair competition and the Drug Safety and the protection of human health. EU sets out the basic requirements for medical products and their performance shall be granted the CE marking of the product and can be placed on the market.
Consumption of medicines and other pharmaceutical supplements are growing, and will be done in the future. For quality research and development is needed to gain that is produced from the sale of pharmaceuticals. Putting pharmaceutical product on the market is not a matter of days rather than months or years. For this reason, it is very necessary cooperation of clinical research and product marketing strategies. A product has three phases, namely, research, development and introduction of drugs into the market. After placing the product on the pharmaceutical market is also necessary to monitor the product and its side effects, this phase is referred to as post-marketing studies.
The area of pharmaceuticals and medical devices is another important area of European health policy. Linked to the EU's responsibility for overseeing compliance with the principles of free movement of pharmaceuticals and medical products as well as high standards of quality and safety.
Since 1985 the EU is trying to create a single European market for pharmaceuticals. The regulation on the one hand, aims at protecting human health, on the other hand, with her trying to create conditions for competition in the pharmaceutical market as well as uniform standards for pharmaceutical research. The EU also oversees the safety of medicines throughout their life cycle (called pharmacovigilance).
The regulation also establishes the basic requirements for medical devices that must be complied with prior to their placing on the market. During their meeting with the awarded products the CE marking.
Our consulting approach incorporates best practices and proven methodologies in strategy alignment, project management, product development and organizational design. We believe that a true best practice is one that fits the organization's goals, culture and complexity.
In keeping with this, we work in collaboration with you, not only assessing gaps but also finding the things you do well and integrating them into your organization’s foundation for building future capability. In this way, we instill the ownership for change where it should be: within your own organization and within each person coming together to deliver the strategy and vision for success.
Innovation is a word used so much these days that it has lost its meaning. Our position on innovation is simple: A company that does not deliver quality products to market, bringing value to the customer and to the business - consistently - is not innovative. Innovation is not a program. Innovation is not a competency by itself. Innovation is a set of core capabilities that are developed with a purpose, interlinked, and supported by a strong commitment to working together.
Trade-product work globally with biotech, pharmaceutical & medical device companies to strengthen and maximize their management practices, resulting in a Product Development Process that effectively manages, and dramatically improves, cross-enterprise productivity.
Our Integrated Product Development (IPD) framework establishes the right linkages between strategy and execution by concentrating on four vital areas:
- Clarifying the Product Strategy and expectations of the organization at all levels so that it provides a true framework for decision-making.
- Establishing a Dynamic Portfolio and Pipeline Management Process that generates the right balance of strategic investments and tactical execution capabilities.
- Improving productivity through Integrated Resource Management.
- Building fast execution capability by embracing consistent Project Management Practices that help manage and track execution within and across functions and geographies.